Immunization status of the 23-valent pneumococcal polysaccharide vaccine among elderly aged 65 and older in South Korea

被引：0
|
作者：
Kim, Jeong Ah [1 ]
Won, Heehyun [1 ]
Jeong, Na-Young [2 ]
Choi, Nam-Kyong [1 ]
机构：
[1] Ewha Womans Univ, Dept Hlth Convergence, Coll Sci & Ind Convergence, Seoul, South Korea
[2] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
628
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [41] The Serological Response Of Asthmatics To The 23-Valent Pneumococcal Polysaccharide Vaccine (ppsv23)
    Laratta, C. R.
    Williams, K.
    Vethanayagam, D.
    Ulanova, M.
    Vliagoftis, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [42] Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children
    Sigurdardottir, Sigurveig Th.
    Center, Kimberly J.
    Davidsdottir, Katrin
    Arason, Vilhjalmur A.
    Hjalmarsson, Bjorn
    Elisdottir, Ragnheidur
    Ingolfsdottir, Gunnhildur
    Northington, Robert
    Scott, Daniel A.
    Jonsdottir, Ingileif
    VACCINE, 2014, 32 (03) : 417 - 424
  • [43] 23-valent pneumococcal polysaccharide vaccine and the risk of renal progression in older patients with chronic kidney disease
    Chang, Po-Ya
    Lin, Chun-Ji
    Chen, Hao-Cheng
    Fan, Hueng-Chuen
    Kuo, Hsuchung
    PREVENTIVE MEDICINE, 2023, 177
  • [44] A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older
    Kawakami, Kenji
    Nakamura, Atsushi
    Wakana, Akira
    Folaranmi, Temitope A.
    Iino, Tomoharu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (07) : 1521 - 1528
  • [45] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Bennett, Nancy M.
    Pilishvili, Tamara
    Whitney, Cynthia G.
    Moore, Matthew
    Gierke, Ryan
    Harris, Aaron M.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (25): : 521 - 524
  • [46] Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses
    Kawakami, Kenji
    Kishino, Hiroyuki
    Kanazu, Shinichi
    Toshimizu, Nobuhito
    Takahashi, Kenichi
    Sterling, Tina
    Wang, Meihua
    Musey, Luwy
    VACCINE, 2016, 34 (33) : 3875 - 3881
  • [47] Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in elderly residents of a long-term care facility
    Valenzuela B., M. Teresa
    Altuzarra H., Rogelio
    Trucco A., Olivia
    Villegas R., Rodrigo
    Inostroza S., Jaime
    Granata S., Paulo
    Fleiderman V., Jose
    Maggi C., Leonardo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03): : 322 - 326
  • [48] SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1180
  • [49] PHARMACOECONOMIC EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CANADIAN ADULTS
    Chuck, A.
    Waye, A.
    Zanotti, G.
    Jacobs, P.
    Kellner, J.
    Tyrrell, G.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [50] Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine
    Yoon, Dongwon
    Jeon, Ha-Lim
    Kim, Ju Hwan
    Lee, Hyesung
    Shin, Ju-Young
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352597
12345